SIGYN THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
SIGYN THERAPEUTICS, INC. (SIGY) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $60.32 thousand as of 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Notes › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2024-02-20
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $60.32K.
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.15M.
- 2018-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.15M.
- 2017-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.12M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2023-12-31 | $60.32K 10-K · filed 2024-02-20 |
| 2019-12-31 | $1.15M 10-K · filed 2020-03-30 |
| 2018-12-31 | $1.15M 10-K · filed 2020-03-30 |
| 2017-12-31 | $1.12M 10-K · filed 2019-04-01 |
| 2015-12-31 | $621.46K 10-K · filed 2016-03-30 |
| 2014-12-31 | $64.88K 10-K · filed 2016-03-30 |